Chief Executive Officer, Kimberly-Clark
Appears in 2 stories
Delivered Q1 2026 results on April 28; framing tariffs as a temporary externality while restructuring supply chains
Three major US household-goods makers have now reported how the combined tariff and oil-cost shock hits their books. Kimberly-Clark beat Q1 estimates on April 28, with adjusted EPS of $1.97 against an expected $1.92, but still carries $300 million in tariff exposure representing about 20% of its US cost base. Colgate-Palmolive beat Q1 expectations on May 1 and immediately flipped its full-year gross margin guidance from expansion to decline, citing $300 million in higher raw-material and logistics costs from crude oil and tariffs.
Updated May 31
Will lead combined company as Chairman and CEO
Johnson & Johnson spun off its consumer health division as Kenvue in May 2023, creating the world's largest pure-play consumer health company. In less than three years, Kimberly-Clark and Kenvue shareholders approved a $48.7 billion acquisition absorbing Kenvue into Kimberly-Clark, the Kleenex and Huggies makerβwith 96% and 99% voting in favor. On January 30, 2026, The Lancet published a study finding no evidence linking acetaminophen use during pregnancy to autism, contradicting Trump administration concerns that sent Kenvue's stock tumbling in late 2025.
Updated May 23
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?